Published in Orphanet J Rare Dis on June 07, 2007
Optimal management of renal artery fibromuscular dysplasia. Ther Clin Risk Manag (2014) 1.03
Spontaneous Dissection of the Renal Artery in Vascular Ehlers-Danlos Syndrome. Case Rep Crit Care (2015) 0.87
Fibromuscular dysplasia: what the radiologist should know: a pictorial review. Insights Imaging (2015) 0.84
Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry. Pediatr Nephrol (2015) 0.82
A case of treatable hypertension: fibromuscular dysplasia of renal arteries. BMC Res Notes (2016) 0.81
Diagnosis and treatment of renal artery stenosis. Nat Rev Nephrol (2010) 0.80
Renal artery rupture following cutting balloon angioplasty for fibromuscular dysplasia: a case report. Cases J (2009) 0.79
Thrombolytic stroke treatment of a 12-year-old girl with intracranial fibromuscular dysplasia. Case Rep Neurol (2011) 0.79
Surgical Treatment of Renal Fibromuscular Dysplasia in a Young Child. Case Rep Surg (2015) 0.78
An Unusual Case of Fibromuscular Dysplasia with Bilateral Renal Macroaneurysms: Three-year Outcome After Endovascular Treatment. Open Cardiovasc Med J (2013) 0.76
Internal Carotid Artery Fibromuscular Dysplasia in a Child: Incidental Postmortem Finding after Head Injury. J Lab Physicians (2017) 0.75
Fibromuscular dysplasia--a rare cause of renovascular hypertension. Case study and overview of the literature data. J Med Life (2012) 0.75
Conditions presenting with symptoms of peripheral arterial disease. Semin Intervent Radiol (2014) 0.75
PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance. PLoS Genet (2016) 0.75
Resistant Hypertension due to Fibromuscular Dysplasia in a Young Male: A Rare Case Report. J Clin Diagn Res (2016) 0.75
Fibromuscular dysplasia presenting as macroscopic hematuria and radiologically sporting a 'clover leaf appearance'. Indian J Nephrol (2013) 0.75
Kidney transplantation in infantile myofibromatosis and fibromuscular dysplasia: a case report. J Med Case Rep (2015) 0.75
A Case of Intraparenchymal Pseudoaneurysms in Kidney Allograft. Am J Case Rep (2016) 0.75
A New Sign for Internal Carotid Artery Dissection Diagnosis by Ultrasound: An Unusual Curve of Bloodstream. Chin Med J (Engl) (2016) 0.75
Focal Renal Arterial Fibromuscular Dysplasia Demonstrated via Intravascular Ultrasound Image. Ann Vasc Dis (2011) 0.75
Fibromuscular dysplasia: a rare disease that can mimic vasculitis. Rheumatol Int (2010) 0.75
Cervical Arterial Fibromuscular Dysplasia in a Biethnic Population: A Retrospective Study in the U.S.-Mexican Border. Int J Angiol (2016) 0.75
Cerebrovascular fibromuscular dysplasia: The MGH cohort and literature review. Neurol Clin Pract (2017) 0.75
Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2 mutations. Pediatr Nephrol (2011) 0.75
Renal hypertension: an unusual cause for a common problem. Eur J Pediatr (2013) 0.75
Disseminated multiple ostial stenoses in a young woman presenting as unstable angina. Rheumatol Int (2008) 0.75
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med (2001) 7.67
Aneurysmal subarachnoid hemorrhage. N Engl J Med (2006) 5.35
Cerebral aneurysms. N Engl J Med (2006) 4.88
Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med (2004) 3.38
Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med (2001) 2.02
Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc (1971) 1.71
Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens (2003) 1.59
Endovascular management of spontaneous carotid artery dissection. J Vasc Surg (2005) 1.48
Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J Hypertens (2006) 1.47
Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med (1968) 1.46
Vascular Ehlers-Danlos syndrome. Ann Genet (2004) 1.44
A pathologic-arteriographic correlation of renal arterial disease. Am Heart J (1966) 1.36
The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am (1984) 1.31
Arterial fibromuscular dysplasia. Mayo Clin Proc (1987) 1.30
Isolated spontaneous dissection of the renal artery. J Vasc Surg (2001) 1.21
Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke (1982) 1.17
Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke (1982) 1.12
The genetics of fibromuscular dysplasia. Arch Intern Med (1980) 1.11
Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens (1997) 1.09
Angiographic spectrum of cervical and intracranial fibromuscular dysplasia. Stroke (1977) 1.08
Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension (1989) 1.08
The string-of-beads sign. Radiology (1998) 1.04
Natural history of renal arterial disease. Radiology (1968) 1.00
Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. Radiology (1989) 0.99
Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension (1993) 0.99
Fatal mesenteric fibromuscular dysplasia: a case report and review of the literature. Arch Intern Med (2004) 0.98
The rational clinical examination. Is listening for abdominal bruits useful in the evaluation of hypertension? JAMA (1995) 0.96
Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery. Radiology (2000) 0.96
Disruption of the elastin gene in adult Williams syndrome is accompanied by a paradoxical reduction in arterial stiffness. Clin Sci (Lond) (2002) 0.93
Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg (1998) 0.93
Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ (1990) 0.93
Incidence of donor renal fibromuscular dysplasia: does it justify routine angiography? Transplantation (2002) 0.92
Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens (2007) 0.91
Cigarette smoking and renovascular hypertension. Lancet (1983) 0.88
Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology (1981) 0.88
Fibromuscular disease of the renal artery: a new histopathologic classification. Ann Vasc Surg (1992) 0.87
Congenital fibromuscular dysplasia involving multivessels in an infant with fatal outcome. Eur J Pediatr (2004) 0.87
Results and significance of angiography in potential kidney donors. Radiology (1979) 0.86
Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens (2001) 0.84
Severe hypoplasia of the abdominal aorta and its branches in a patient and his daughter. J Intern Med (2004) 0.83
Bilateral fibromuscular dysplasia in identical twins. Am J Kidney Dis (1998) 0.82
Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. J Hypertens (2006) 0.80
Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. J Hum Hypertens (1999) 0.78
HYPERTENSION CAUSED BY FIBROMUSCULAR DYSPLASIA OF THE RENAL ARTERIES. Postgrad Med (1965) 0.77
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke (2003) 4.10
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab (2005) 4.07
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet (2006) 3.65
Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev (2005) 3.46
Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol (2007) 3.41
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab (2007) 3.25
SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell (2013) 3.24
Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol (2005) 3.20
SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet (2010) 3.07
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol (2009) 3.05
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet (2013) 2.83
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 2.72
Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens (2012) 2.71
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet (2007) 2.64
Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension (2009) 2.58
Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol (2011) 2.49
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Structural and genetic bases of arterial stiffness. Hypertension (2005) 2.31
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res (2003) 2.29
European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens (2014) 2.28
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab (2009) 2.22
Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension (2009) 2.20
Aortic stiffness measurement improves the prediction of asymptomatic coronary artery disease in stroke/transient ischemic attack patients. Int J Stroke (2013) 2.07
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab (2007) 2.06
Unknown complication of arterial switch operation: resistant hypertension induced by a strong aortic arch angulation. Circulation (2013) 2.02
Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation (2007) 1.99
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93
Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension (2011) 1.89
Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens (2011) 1.89
Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab (2002) 1.84
Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol (2003) 1.76
The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One (2009) 1.75
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab (2005) 1.75
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens (2011) 1.72
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension (2006) 1.72
Functionality of two new polymorphisms in the human renin gene enhancer region. J Hypertens (2002) 1.65
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol (2008) 1.62
Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation (2012) 1.61
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun (2013) 1.60
Oncometabolites-driven tumorigenesis: From genetics to targeted therapy. Int J Cancer (2014) 1.60
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J Hypertens (2012) 1.59
Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens (2003) 1.59
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood (2004) 1.59
Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension (2007) 1.59
Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol (2011) 1.57
Carotid and aortic stiffness: determinants of discrepancies. Hypertension (2006) 1.56
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51
Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol (2007) 1.49
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer (2009) 1.48
Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging. JACC Cardiovasc Imaging (2011) 1.48
True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence. J Hypertens (2015) 1.47
Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg (2012) 1.47
Genetic influences on the arterial wall. Clin Exp Pharmacol Physiol (2007) 1.47
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Heart rate variability and functional outcome in ischemic stroke: a multiparameter approach. J Hypertens (2013) 1.46
Blood pressure loci identified with a gene-centric array. Am J Hum Genet (2011) 1.44
Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies. Hypertension (2012) 1.44
Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice. Hypertension (2013) 1.43
Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension (2012) 1.43
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab (2011) 1.42
Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis (2006) 1.41
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet (2011) 1.38
Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int (2012) 1.38
Arterial remodeling associates with CKD progression. J Am Soc Nephrol (2011) 1.32
An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens (2010) 1.26
Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension (2009) 1.25
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab (2010) 1.24
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res (2012) 1.22
Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology (2011) 1.21
Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J (2012) 1.21
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum Mol Genet (2005) 1.21
Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat (2013) 1.18
Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. Proc Natl Acad Sci U S A (2010) 1.18
Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension (2010) 1.18
Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab (2009) 1.18
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab (2009) 1.15
Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2005) 1.15
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet (2013) 1.14
Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation (2005) 1.13
Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens (2013) 1.12
Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clin Endocrinol (Oxf) (2007) 1.11
Recent advances in the genetics of phaeochromocytoma and functional paraganglioma. Clin Exp Pharmacol Physiol (2008) 1.10
Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension (2009) 1.10
Pheochromocytomas: the (pseudo)-hypoxia hypothesis. Best Pract Res Clin Endocrinol Metab (2010) 1.09
Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab (2004) 1.09